rs60734921

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP4BP6BS1BS2

The NM_021098.3(CACNA1H):​c.1853C>T​(p.Pro618Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000919 in 1,585,064 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P618S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00048 ( 1 hom., cov: 34)
Exomes 𝑓: 0.00097 ( 2 hom. )

Consequence

CACNA1H
NM_021098.3 missense

Scores

3
12
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3O:1

Conservation

PhyloP100: 3.46

Publications

11 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.34770316).
BP6
Variant 16-1202303-C-T is Benign according to our data. Variant chr16-1202303-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 2705.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000479 (73/152304) while in subpopulation NFE AF = 0.000809 (55/68006). AF 95% confidence interval is 0.000638. There are 1 homozygotes in GnomAd4. There are 37 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High AC in GnomAd4 at 73 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.1853C>T p.Pro618Leu missense_variant Exon 9 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.1853C>T p.Pro618Leu missense_variant Exon 9 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.1853C>T p.Pro618Leu missense_variant Exon 9 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.1853C>T p.Pro618Leu missense_variant Exon 9 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.1853C>T p.Pro618Leu missense_variant Exon 9 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.1853C>T p.Pro618Leu missense_variant Exon 9 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.1853C>T p.Pro618Leu missense_variant Exon 9 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.1814C>T p.Pro605Leu missense_variant Exon 9 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.1853C>T p.Pro618Leu missense_variant Exon 9 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.1814C>T p.Pro605Leu missense_variant Exon 9 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.1853C>T p.Pro618Leu missense_variant Exon 9 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.1853C>T p.Pro618Leu missense_variant Exon 9 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.1853C>T p.Pro618Leu missense_variant Exon 9 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.1853C>T p.Pro618Leu missense_variant Exon 9 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.1853C>T p.Pro618Leu missense_variant Exon 9 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.1853C>T non_coding_transcript_exon_variant Exon 9 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.1853C>T non_coding_transcript_exon_variant Exon 9 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.1853C>T non_coding_transcript_exon_variant Exon 9 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000711442.1 linkn.*1300C>T non_coding_transcript_exon_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.1853C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.1853C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.1853C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.1853C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.1853C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.1853C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.1853C>T non_coding_transcript_exon_variant Exon 9 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.1853C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.1853C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518777.1
CACNA1HENST00000711442.1 linkn.*1300C>T 3_prime_UTR_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000640028.1 linkn.1385+468C>T intron_variant Intron 9 of 34 5 ENSP00000491488.1 A0A1W2PQ19

Frequencies

GnomAD3 genomes
AF:
0.000480
AC:
73
AN:
152186
Hom.:
1
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000809
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000536
AC:
105
AN:
196016
AF XY:
0.000493
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000334
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000183
Gnomad NFE exome
AF:
0.000992
Gnomad OTH exome
AF:
0.000974
GnomAD4 exome
AF:
0.000966
AC:
1384
AN:
1432760
Hom.:
2
Cov.:
57
AF XY:
0.000970
AC XY:
689
AN XY:
710164
show subpopulations
African (AFR)
AF:
0.000122
AC:
4
AN:
32802
American (AMR)
AF:
0.000268
AC:
11
AN:
40982
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25544
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37862
South Asian (SAS)
AF:
0.0000979
AC:
8
AN:
81732
European-Finnish (FIN)
AF:
0.000164
AC:
8
AN:
48818
Middle Eastern (MID)
AF:
0.000349
AC:
2
AN:
5736
European-Non Finnish (NFE)
AF:
0.00119
AC:
1307
AN:
1099918
Other (OTH)
AF:
0.000741
AC:
44
AN:
59366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
83
166
250
333
416
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
46
92
138
184
230
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000479
AC:
73
AN:
152304
Hom.:
1
Cov.:
34
AF XY:
0.000497
AC XY:
37
AN XY:
74472
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41578
American (AMR)
AF:
0.000196
AC:
3
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5168
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.000809
AC:
55
AN:
68006
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
3
7
10
14
17
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000851
Hom.:
0
Bravo
AF:
0.000521
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.000265
AC:
1
ESP6500EA
AF:
0.000498
AC:
4
ExAC
AF:
0.000530
AC:
62

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
May 14, 2018
Athena Diagnostics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2021
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 10, 2025
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 17696120, 15852375, 30197081, 32227660, 34426522, 15048902) -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Jan 08, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epilepsy, idiopathic generalized, susceptibility to, 6 Other:1
May 01, 2005
OMIM
Significance:risk factor
Review Status:no assertion criteria provided
Collection Method:literature only

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Uncertain
0.068
T
BayesDel_noAF
Pathogenic
0.27
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.50
T;.;.;.
Eigen
Uncertain
0.47
Eigen_PC
Uncertain
0.40
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Uncertain
0.89
D;D;D;.
M_CAP
Pathogenic
0.30
D
MetaRNN
Benign
0.35
T;T;T;T
MetaSVM
Uncertain
0.58
D
MutationAssessor
Uncertain
2.5
M;.;M;M
PhyloP100
3.5
PrimateAI
Uncertain
0.77
T
PROVEAN
Pathogenic
-4.6
D;.;D;D
REVEL
Uncertain
0.62
Sift
Uncertain
0.020
D;.;D;D
Sift4G
Benign
0.18
T;.;T;T
Polyphen
0.89
P;.;D;D
Vest4
0.58
MVP
0.95
ClinPred
0.52
D
GERP RS
4.1
Varity_R
0.29
gMVP
0.63
Mutation Taster
=58/42
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60734921; hg19: chr16-1252303; API